acimmune.com · 734
AC Immune SA is a global leader in developing precision medicine for neurodegenerative diseases, with a focus on conditions such as Alzheimer's and Parkinson's. The company utilizes cutting-edge technology platforms to pioneer new ways to diagnose, treat, and prevent neurodegeneration. AC Immune has received FDA Fast Track Designation for their anti-Abeta active immunotherapy ACI-24.060, aimed at treating Alzheimer's. They are also developing vaccine strategies to prevent both Alzheimer's and Parkinson's disease. AC Immune's technology platforms, Morphomer® and Supraantigen®, deliver top-tier small molecules and biologics. They have a broad pipeline focused on neurodegenerative diseases and are committed to pioneering precision medicine in the field. AC Immune is currently partnering on a Phase 3 study of Tau-PET diagnostic PI-2620 for Alzheimer's disease.
acimmune.com · years statistic
2003
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 1 |
| 5 | 0 |
| 6 | 1 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2004
| 1 | 1 |
| 2 | 0 |
| 3 | 1 |
| 4 | 1 |
| 5 | 2 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 5 |
| 10 | 1 |
| 11 | 0 |
| 12 | 2 |
2005
| 1 | 1 |
| 2 | 3 |
| 3 | 3 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 1 |
| 12 | 2 |
2006
| 1 | 2 |
| 2 | 2 |
| 3 | 1 |
| 4 | 4 |
| 5 | 0 |
| 6 | 3 |
| 7 | 0 |
| 8 | 7 |
| 9 | 8 |
| 10 | 2 |
| 11 | 0 |
| 12 | 1 |
2007
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 1 |
| 10 | 6 |
| 11 | 0 |
| 12 | 1 |
2008
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 1 |
| 5 | 0 |
| 6 | 1 |
| 7 | 1 |
| 8 | 15 |
| 9 | 8 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2010
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 3 |
| 10 | 3 |
| 11 | 1 |
| 12 | 3 |
2011
| 1 | 0 |
| 2 | 4 |
| 3 | 2 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2012
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 1 |
| 5 | 0 |
| 6 | 1 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 1 |
| 12 | 0 |
2013
| 1 | 0 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 2 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2014
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2015
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2016
| 1 | 3 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 1 |
| 6 | 4 |
| 7 | 1 |
| 8 | 2 |
| 9 | 2 |
| 10 | 3 |
| 11 | 1 |
| 12 | 0 |
2017
| 1 | 0 |
| 2 | 2 |
| 3 | 0 |
| 4 | 0 |
| 5 | 2 |
| 6 | 3 |
| 7 | 2 |
| 8 | 2 |
| 9 | 2 |
| 10 | 1 |
| 11 | 1 |
| 12 | 1 |
2018
| 1 | 1 |
| 2 | 1 |
| 3 | 4 |
| 4 | 5 |
| 5 | 6 |
| 6 | 4 |
| 7 | 4 |
| 8 | 10 |
| 9 | 6 |
| 10 | 5 |
| 11 | 7 |
| 12 | 5 |
2019
| 1 | 7 |
| 2 | 6 |
| 3 | 5 |
| 4 | 2 |
| 5 | 4 |
| 6 | 2 |
| 7 | 3 |
| 8 | 2 |
| 9 | 4 |
| 10 | 3 |
| 11 | 1 |
| 12 | 1 |
2020
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 26 |
| 5 | 14 |
| 6 | 16 |
| 7 | 22 |
| 8 | 26 |
| 9 | 35 |
| 10 | 29 |
| 11 | 21 |
| 12 | 1 |
2021
| 1 | 2 |
| 2 | 1 |
| 3 | 3 |
| 4 | 4 |
| 5 | 8 |
| 6 | 18 |
| 7 | 1 |
| 8 | 4 |
| 9 | 6 |
| 10 | 11 |
| 11 | 13 |
| 12 | 16 |
2022
| 1 | 11 |
| 2 | 3 |
| 3 | 9 |
| 4 | 13 |
| 5 | 13 |
| 6 | 10 |
| 7 | 9 |
| 8 | 8 |
| 9 | 11 |
| 10 | 8 |
| 11 | 5 |
| 12 | 7 |
2023
| 1 | 4 |
| 2 | 12 |
| 3 | 6 |
| 4 | 7 |
| 5 | 9 |
| 6 | 11 |
| 7 | 3 |
| 8 | 8 |
| 9 | 5 |
| 10 | 4 |
| 11 | 3 |
| 12 | 0 |
2024
| 1 | 2 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
acimmune.com · links
Medical Research
United States
English
ajog.org
14,637
American Journal of Obstetrics & Gynecology
